Debunked Claims
Every claim below has been evaluated against peer-reviewed evidence and guidance from CDC and WHO.
"Ebola spreads through the air like a cold"
The claim: Ebola can be transmitted by breathing the same air as an infected person.
The evidence: Ebola is not transmitted via the airborne route under normal conditions. The CDC states plainly that Ebola does not spread the same way as respiratory viruses like flu and COVID, that you cannot get it from being near someone, and that it is not spread through airborne transmission.[1] Transmission requires direct contact with infected body fluids. This misconception causes unnecessary panic and discriminatory treatment of people from affected regions.
"There is a secret cure being withheld"
The claim: Pharmaceutical companies or governments possess a cure for Ebola but are withholding it for financial or political reasons.
The evidence: Two FDA-approved monoclonal antibody treatments (Inmazeb and Ebanga) were developed following the 2014–16 epidemic and are used in current outbreak responses. Far from being withheld, these therapies are openly recommended: WHO makes a strong recommendation for both mAb114 (Ebanga) and REGN-EB3 (Inmazeb) for Ebola virus disease.[2] These were made available through humanitarian programs. The real challenge is manufacturing capacity and distribution in remote, conflict-affected regions — not secrecy or suppression.
"Vaccines are being used for population control in Africa"
The claim: Ebola vaccines are a Western conspiracy to reduce African populations or conduct medical experiments.
The evidence: The Ervebo vaccine was developed in collaboration with African scientists and governments, underwent rigorous clinical trials with full informed consent in Guinea and DRC, and was found safe and highly effective. Vaccine hesitancy driven by this conspiracy theory contributed to preventable deaths in the 2018–20 DRC outbreak.
"Ebola patients should be treated at home, not hospitals"
The claim: Sending an Ebola patient to a hospital or Ebola Treatment Unit (ETU) is a death sentence; they should be treated at home.
The evidence: This belief, common in some affected communities during the 2014–16 epidemic, was tragically counterproductive. Early treatment at ETUs significantly improves survival through supportive care, antivirals, and monitoring. Home care dramatically increases transmission risk to family members and was a primary driver of community spread during the West Africa epidemic.
"Traditional remedies can cure Ebola"
The claim: Various traditional medicines, plant remedies, or ritual practices can treat or prevent Ebola.
The evidence: No traditional remedy has demonstrated efficacy against Ebola in clinical evidence. WHO identifies only two approved therapeutics for Ebola virus disease — mAb114 (Ebanga) and REGN-EB3 (Inmazeb) — alongside optimized supportive care, and stresses that early intensive supportive care with rehydration and treatment of symptoms improves survival.[2] Reliance on unproven remedies delays patients from accessing that effective care, worsening outcomes and increasing transmission. Traditional healers who treat patients without protective equipment are at very high infection risk and have been sources of outbreak amplification in past epidemics.
"You can get Ebola from someone who looks healthy"
The claim: Ebola can be transmitted by people who appear well and show no symptoms.
The evidence: People with Ebola are not infectious during the incubation period (2–21 days after exposure). The CDC states that a person is only contagious once they begin showing symptoms of the disease.[1] This is a key distinction that makes Ebola outbreak containment possible through symptom-based surveillance and isolation.
References
- Centers for Disease Control and Prevention. "How Ebola Disease Spreads." cdc.gov/ebola/causes
- World Health Organization. "Ebola disease" fact sheet — treatment and supportive care. who.int/news-room/fact-sheets/detail/ebola-disease
Why Misinformation Is Deadly in Outbreaks
The Real-World Cost of Ebola Myths
Misinformation during Ebola outbreaks is not merely false — it kills people. During the 2014–16 West Africa epidemic, misinformation contributed to:
- Patients hiding symptoms and avoiding ETUs, increasing household transmission
- Healthcare workers being attacked while trying to conduct safe burials
- Contact tracing teams being turned away or assaulted in affected communities
- Families performing traditional burial practices on Ebola-positive bodies, causing cluster outbreaks
During the 2018–20 DRC outbreak — then the second-largest in history — armed attacks on healthcare workers and ETUs, often fueled by conspiracy theories and distrust, contributed significantly to the duration and scale of the outbreak.
Accurate information, delivered with respect for communities and their concerns, is a core component of effective outbreak response.
What Misinformation Is Costing the 2026 Response — in CDC's and WHO's Own Words
CDC's situation summary (September 14, 2026) lists "lack of trust in the government and misinformation" as one of five response challenges, alongside conflict, infrastructure, violence against health workers, and population movement. The measurable consequences appear in CDC's operational review: 59% of confirmed deaths were occurring outside a treatment unit, which CDC attributes to "insufficient ETU capacity, fear of ETUs, and ongoing spread through unidentified transmission chains," and only 15–20% of new cases had been previously identified as contacts (CDC MMWR 2026;75(35):554). Fear of treatment units is the "home care" myth above, at scale.
The single clearest 2026 example of the body-handling myth's cost is from Uganda: four Ugandan health workers were infected during the attempted resuscitation of a probable case who died and was embalmed before diagnostic testing could be completed, and a driver was infected through contact with a body (CDC MMWR 2026;75(35):551). Five of Uganda's six locally acquired infections came from one body handled as if it were not infectious.
There is also a number for rumours. Between May 18 and August 28, 2026, WHO's public health intelligence identified 76 Ebola-related signals across 23 countries — suspected cases among travellers and health workers, and reports circulating in public sources. 92% (70 of 76) were ruled out by investigation and laboratory testing; six were confirmed as Ebola events (WHO DON 616). Roughly nine of every ten "Ebola case" reports that reached WHO from outside the outbreak zone were false.
How to Check an Ebola Claim Yourself
The claims change; the checks do not. Five questions, each with the primary source that answers it during the 2026 outbreak.
- Is the case count from CDC or WHO, and what is its date? CDC's situation summary gives DRC's count with an "as of" date and a footnote on what is excluded (suspected cases are currently not counted); WHO's Disease Outbreak News gives its own count with its own date, usually a few days earlier. A number without a date and a source is not a number. As of this review, CDC reported 7,200 confirmed cases in DRC as of September 12, 2026 and WHO 6,757 as of September 7 — both correct for their dates.
- Does the claim about a vaccine or drug distinguish the species? Every licensed product is for Ebola (Zaire) virus. The FDA labels for Inmazeb and Ebanga say efficacy "has not been established for other species"; CDC's clinical guidance says there are no FDA-approved treatments or vaccines for Bundibugyo virus. Any claim that "the Ebola vaccine" is being withheld from — or forced on — DRC in 2026 fails this check: Ervebo is being given to health workers under a WHO research protocol precisely because its effect against this species is unknown (WHO DON 617).
- Is a "cure" claim describing a trial or a result? WHO's PARTNERS therapeutics trial has enrolled more than 300 patients (DON 617). Enrolment is not efficacy. No result has been published. The only drug data are 18 uncontrolled Ugandan patients given remdesivir, whose authors say a trial "might be warranted" — not that it works (CDC MMWR).
- Does a transmission claim survive the "before symptoms" test? CDC and WHO both state that people are not infectious before symptoms. A story about a healthy-looking traveller "spreading Ebola" on a flight has to explain how; the 2026 exported case to France was a physician who self-reported symptoms on landing, and none of his five flight contacts or 107 Kinshasa contacts became ill (WHO DON 612–614).
- Is the fatality figure a crude ratio or a known-outcome rate — and for which species? "Ebola kills 90%" is the upper end of WHO's 25–90% historical range and refers to Zaire virus in 1976. The 2026 crude CFR in DRC is 48%; Uganda's confirmed cases had 10%; the historical Bundibugyo pooled rate is 32.8% (95% CI 25.8–40.2; Izudi et al., 2024). See the symptoms page for why these differ.
Compared to what? Misinformation thrives on scale without comparison. For Ebola's exposure, hospitalisation and death rates alongside 14 other viruses, see the Virus Risk Perspective and this site's Ebola risk perspective.
Why These Specific Myths Persist — and Why They Are Hard to Counter
The Structure of Outbreak Misinformation
The myths debunked above are not random. Each one has a structural reason for persisting, and understanding that structure matters for anyone trying to counter it — whether a healthcare worker, a public health official, or a journalist.
The airborne myth persists because it is superficially plausible. Ebola does produce aerosols in certain medical procedures (intubation, bronchoscopy), and under experimental laboratory conditions with artificially high viral loads, limited primate-to-primate aerosol transmission has been demonstrated. The CDC and WHO position — that Ebola is not transmitted through the air under normal conditions — is accurate but requires understanding what "normal conditions" means here: a nuance that news headlines rarely convey. When people hear that Ebola produces aerosols in hospital settings, they reasonably but incorrectly extend that to mean casual airborne spread. The counter is not simply "it's not airborne" — it is explaining what kind of contact is actually required and why that differs categorically from a cold or flu.
The "secret cure" myth persists for a different reason: it was partially true during the 2014–16 epidemic. Experimental treatments including ZMapp were used under compassionate use protocols, were in very limited supply, and were administered to some Western patients while not available in the affected West African countries. That disparity was real and was widely reported. The transition from "experimental treatment with limited supply" to "approved antiviral available through humanitarian programs" happened over several years and was poorly communicated. The residue of the earlier, partially accurate story now feeds the conspiracy narrative. The accurate counter requires acknowledging the history rather than simply asserting the current state.
The vaccine conspiracy narrative is perhaps the most dangerous because it is most resistant to correction. During the 2018–20 DRC outbreak, the Ervebo vaccine was available and effective, but vaccine hesitancy — driven in part by distrust rooted in a history of genuine exploitation of African research subjects — led to widespread refusal. The WHO report on that outbreak explicitly identified community distrust as a major factor in the outbreak's 29-month duration. The lesson is not that the conspiracy theory was correct; it was not. The lesson is that accurate information delivered without acknowledgment of the legitimate historical grievances behind distrust does not work. Public health communication that starts from community trust rather than factual correction has a meaningfully different outcome.
The body-handling myth is perhaps the one with the most direct link to transmission events. Traditional burial practices involving washing and touching the body of the deceased are central to mourning rites in many affected communities. The virus persists in the body for several days after death at high concentrations. WHO data from the West Africa epidemic attributed approximately 20% of cases directly to unsafe burials. Safe and dignified burial protocols — developed with community input, conducted by trained teams, and designed to accommodate mourning practices as much as possible — reduced this transmission route substantially. The myth that safe burial is disrespectful is, in the data, one of the deadliest Ebola myths on record.
This analysis is for informational purposes only. Sources: WHO Ebola outbreak response reports; CDC Ebola transmission guidance; Coltart et al. (2017) "The Ebola outbreak, 2013–2016: old lessons for new epidemics." Philosophical Transactions of the Royal Society B. doi:10.1098/rstb.2016.0297.
Further Reading
Books that examine the scientific, social, and political forces behind dangerous outbreak myths.
Sources & References
- Centers for Disease Control and Prevention. Ebola Outbreak: Current Situation. Page dated September 14, 2026. cdc.gov/ebola/situation-summary
- Centers for Disease Control and Prevention. How Ebola Disease Spreads. June 2, 2026. cdc.gov/ebola/causes
- Centers for Disease Control and Prevention. Clinical Guidance for Ebola Disease. May 27, 2026. cdc.gov/ebola/hcp/clinical-guidance
- Kabasele D, et al. Notes from the Field: Characteristics and Monitoring of the 2026 Outbreak — DRC, August 2026. MMWR 2026;75(35):554–556. doi:10.15585/mmwr.mm7535e1
- Mutegeki M, et al. Notes from the Field: Clinical Characteristics of Patients — Uganda, 2026. MMWR 2026;75(35):551–553. doi:10.15585/mmwr.mm7535a2
- World Health Organization. Disease Outbreak News 612–617 (July–September 2026): Ebola disease caused by Bundibugyo virus. who.int/…/2026-DON617
- World Health Organization. Ebola disease — fact sheet. Updated May 2026. who.int/news-room/fact-sheets/detail/ebola-disease
- Izudi J, Bajunirwe F. Case fatality rate for Ebola disease, 1976–2022: A meta-analysis of global data. J Infect Public Health 2024;17(1):25–34. doi:10.1016/j.jiph.2023.10.020
- Coltart CEM, et al. The Ebola outbreak, 2013–2016: old lessons for new epidemics. Philos Trans R Soc B 2017;372:20160297. doi:10.1098/rstb.2016.0297
